PINABULIN-ZUSAMMENSETZUNGEN

Patent europeic · EP3334726 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3334726
Numer da la dumonda
EP16824996
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-07-2016
Publitgà
20-06-2018
Concedì
16-03-2022
La protecziun finescha il pli tard
10-07-2036
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
C07D 403/06 (2006.01)
Prioritad
US 201562191990 P 13.07.2015
Dumonda PCT
PCT/US2016/041773 11.07.2016
Publicaziun PCT
WO2017/011399 19.01.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. 01-08-2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. 01-08-2024

    Midada

    Published in Swissreg on 01.08.2024

  4. 01-08-2023

    Midada

    Published in Swissreg on 01.08.2023

  5. 25-01-2023

    Midada

    Published in Swissreg on 25.01.2023

  6. 01-08-2022

    Midada

    Published in Swissreg on 01.08.2022

  7. 16-03-2022

    Concedì

    Published in Swissreg on 16.03.2022

Partidas

Possessur

Beyondspring Pharmaceuticals, Inc.

28 Liberty Street, 39th Floor, New York, NY 10005, US

Inventur

SINGH, Aniruddh

Carteret, NJ 07008, US

HUANG, Lan

New York, NY 10005, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.